Boston An independent LDT provider

Press releases

May 16, 2019

Immunovia’s PanFAM-1: The largest study of hereditary pancreatic cancer risk, gathers momentum in the US

Read press release
May 15, 2019

Immunovia to present at Jefferies 2019 Global Healthcare Conference in New York City, June 4-7 2019

Read press release
April 29, 2019 | REGULATORY

Immunovia announces optimization work is progressing on-schedule and according to plan

Read press release
April 26, 2019 | REGULATORY

Immunovia – Report from AGM

Read press release
April 24, 2019 | REGULATORY

CORRECTION: Immunovia Interim Report, January-March 2019

Read press release
April 24, 2019 | REGULATORY

Immunovia Interim Report, January-March 2019

Read press release
April 12, 2019

Immunovia advances strategic collaboration with primary care physicians in the US to build awareness of the importance of early detection of pancreatic cancer

Read press release
April 10, 2019

Corrected: Immunovia and University College of London sign agreement to expand validation studies of IMMray™ PanCan-d for early signs and symptoms

Read press release
April 8, 2019 | REGULATORY

Immunovia and University College of London sign agreement to extendvalidation studies of IMMray™ PanCan-d for early signs and symptoms

Read press release
March 20, 2019 | REGULATORY

KALLELSE TILL ÅRSSTÄMMA I IMMUNOVIA AB

Read press release
March 4, 2019 | REGULATORY

Immunovia publishes the annual report for the financial year 2018

Read press release
March 4, 2019 | REGULATORY

Immunovia provides an update on the optimization work to meet the expected performance for commercialization of IMMray™ PanCan-d

Read press release
1 18 19 20 21 22 30